ViennaLab Diagnostics GmbH

Discriminate between ApoE variants associated with type III hyperlipoproteinemia, cardiovascular disease and Alzheimer’s disease.

Specific Apolipoprotein E variants have been associated with type III hyperlipoproteinemia (ApoE2), cardiovascular disease and Alzheimer’s disease (ApoE4). ViennaLab Apo E StripAssay® easily discriminates between the E2, E3, and E4 variants of ApoE.




  • ApoE has key roles in the transport of cholesterol and other lipids within blood circulation and the central nervous system.
  • ApoE is polymorphic exhibiting three different alleles, which differ by an alternating combination of two amino acids at position 112 and 158: E2 (C112_C158), E3 (C112_R158) and E4 (R112_R158).
  • ApoE is an important predictor of the plasma lipid profile. On average, LDL-cholesterol concentrations are lower for E2 carriers and higher for E4 carriers compared to homozygous E3 carriers.
  • ApoE2 and ApoE4 have been associated with an increased risk for Cardiovascular Disease (E2), and susceptibility to Alzheimer’s Disease and Coronary Artery Disease (E4) in various studies.
  • Identifying genetic variations in combination with timely life style adaptations may contribute to delay of disease onset.

pdf Productnote 01: CVD Marker


ProductReg. Stat.REFUnit SizeIFUBrochure
Apo E StripAssay® CE/IVD4-28020 tests



We use Matomo to analyze the access to our website. We pass on information about your use of our website to our partners for analysis. Our partners may combine this information with other data that you have provided to them or that they have collected as part of your use of the services. I agree.

Deny Allow